Medical IPOs - Are They Healthy?

IPO Desktop President Francis Gaskins and TheStreet's Debra Borchardt look at the Enanta Pharmaceuticals and Tetraphase Pharmaceuticals offerings.
Author:
Publish date:

Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.